Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Rivaroxaban is an oral, direct Factor Xa inhibitor approved in the European Union and several other countries for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery and is in advanced clinical development for the treatment of thromboembolic disorders. Its mechanism of action is antithrombi...
Alternative Titles
Full title
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1297624052
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1297624052
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0017626
